115 related articles for article (PubMed ID: 23257985)
1. Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibility.
Zhang H; Zhang Z; Wu J; Xu Y; Cheng R; Li L
Urol Int; 2013; 91(2):213-9. PubMed ID: 23257985
[TBL] [Abstract][Full Text] [Related]
2. No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.
Zou LW; Xu XJ; Liu T; Wang HY; Fan WJ; Wang XH; Zhang ZX; Zhai JX
Genet Test Mol Biomarkers; 2013 Jan; 17(1):78-84. PubMed ID: 23116175
[TBL] [Abstract][Full Text] [Related]
3. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis.
Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z
J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589
[TBL] [Abstract][Full Text] [Related]
4. The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis.
Xiao L; Tong M; Jin Y; Huang W; Li Z
Mol Biol Rep; 2013 Feb; 40(2):1835-41. PubMed ID: 23096092
[TBL] [Abstract][Full Text] [Related]
5. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
6. The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM).
Feng Y; Zhao X; Zhou C; Yang L; Liu Y; Bian C; Gou J; Lin X; Wang Z; Zhao X
Gene; 2013 Oct; 529(2):296-9. PubMed ID: 23939469
[TBL] [Abstract][Full Text] [Related]
7. Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.
Lin G; Zhao J; Wu J; Andreevich O R; Zhang WH; Zhang Y; Yu L
Genet Mol Res; 2013 Dec; 12(4):6442-53. PubMed ID: 24390993
[TBL] [Abstract][Full Text] [Related]
8. The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
Suzuki M; Mamun MR; Hara K; Ozeki T; Yamada Y; Kadowaki T; Honda H; Yanagihara Y; Ito YM; Kameyama S; Ohta N; Hosoi T; Arai T; Sawabe M; Takeuchi T; Takahashi S; Kitamura T
Eur Urol; 2005 Nov; 48(5):752-9. PubMed ID: 16126332
[TBL] [Abstract][Full Text] [Related]
9. Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria.
Lajin B; Hamzeh AR; Ghabreau L; Mohamed A; Al Moustafa AE; Alachkar A
Breast Cancer; 2013 Jan; 20(1):62-6. PubMed ID: 22124994
[TBL] [Abstract][Full Text] [Related]
10. The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis.
Liao YJ; Jiang JR; Jin SQ
Cephalalgia; 2017 May; 37(6):592-598. PubMed ID: 27154995
[TBL] [Abstract][Full Text] [Related]
11. Association between Val158Met functional polymorphism in the COMT gene and risk of preeclampsia in a Chinese population.
Liang S; Liu X; Fan P; Liu R; Zhang J; He G; Liu Y; Bai H
Arch Med Res; 2012 Feb; 43(2):154-8. PubMed ID: 22475780
[TBL] [Abstract][Full Text] [Related]
12. The association between COMT Val158Met gene polymorphism and antipsychotic-induced tardive dyskinesia risk.
Lv Z; Rong B; Tong X; Li X; Chen X; Wang X; Li Z
Int J Neurosci; 2016 Nov; 126(11):1044-50. PubMed ID: 26398367
[TBL] [Abstract][Full Text] [Related]
13. Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.
Tan X; Chen M
Diagn Pathol; 2014 Oct; 9():192. PubMed ID: 25280560
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
15. The Association between COMT Val158Met Polymorphism and the Post-Traumatic Stress Disorder Risk: A Meta-Analysis.
Su M; Song Y
Neuropsychobiology; 2022; 81(2):156-170. PubMed ID: 34657037
[TBL] [Abstract][Full Text] [Related]
16. The catechol-O-methyl transferase Val158Met polymorphism and susceptibility to cannabis dependence.
Baransel Isir AB; Oguzkan S; Nacak M; Gorucu S; Dulger HE; Arslan A
Am J Forensic Med Pathol; 2008 Dec; 29(4):320-2. PubMed ID: 19259017
[TBL] [Abstract][Full Text] [Related]
17. Lack of associations of the COMT Val158Met polymorphism with risk of endometrial and ovarian cancer: a pooled analysis of case-control studies.
Liu JX; Luo RC; Li R; Li X; Guo YW; Ding DP; Chen YZ
Asian Pac J Cancer Prev; 2014; 15(15):6181-6. PubMed ID: 25124595
[TBL] [Abstract][Full Text] [Related]
18. Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.
Qin X; Peng Q; Qin A; Chen Z; Lin L; Deng Y; Xie L; Xu J; Li H; Li T; Li S; Zhao J
Diagn Pathol; 2012 Oct; 7():136. PubMed ID: 23039364
[TBL] [Abstract][Full Text] [Related]
19. Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls.
He XF; Wei W; Li SX; Su J; Zhang Y; Ye XH; Liu Y; Wang W
Mol Biol Rep; 2012 Jun; 39(6):6811-23. PubMed ID: 22297695
[TBL] [Abstract][Full Text] [Related]
20. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]